Who is sponsoring NCT05989633?

NCT05989633 is sponsored by Cosmetique Active International.

What drugs are being tested in NCT05989633?

Interventions in NCT05989633: Dermocosmetic product: Selenium Disluphide Shampoo (Dercos DS).

Is NCT05989633 still recruiting?

NCT05989633 is currently completed. Last updated 14 August 2023.

Last reviewed 2023-08-14 · How we verify

NCT05989633

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

DERCOS DS DANDRUFF TREATMENT OBSERVATIONAL STUDY 2022

Completed Last updated 14 August 2023

What this trial tests

trial testing Dermocosmetic product: Selenium Disluphide Shampoo (Dercos DS) in Dandruff in 5,131 participants. Completed in 29 June 2023.

Timeline

4 July 2022

Primary endpoint
29 June 2023

29 June 2023

Quick facts

Lead sponsor	Cosmetique Active International
Status	Completed
Study type	OBSERVATIONAL
Enrollment	5,131
Start date	4 July 2022
Primary completion	29 June 2023
Estimated completion	29 June 2023
Sites	1 location across Poland

Drugs / interventions tested

Dermocosmetic product: Selenium Disluphide Shampoo (Dercos DS)

Conditions studied

Dandruff — all drugs for Dandruff →

Sponsor

Cosmetique Active International — full company profile →

Who can join

12 and older, any sex, with Dandruff. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate the satisfaction / tolerance / cosmeticity of Dercos DS

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dandruff

Currently open trials in the same condition.

NCT06813521 — Antidandruff Lotion Mediating Microbiome Rebalance · NA · recruiting

Other Cosmetique Active International trials

Trials by the same sponsor.

NCT07239726 — CLINICAL INVESTIGATION TO EVALUATE THE EFFICACY AND SAFETY OF EPILADY PROTOTYPE DEVICE FOLLOWED BY APPLICATION OF A TOPI · NA · not yet recruiting
NCT06590779 — Benefits of a Cosmetic Anti-hair Loss in Males With Hair Loss · NA · not yet recruiting
NCT06516224 — Anti-pigmenting Effect of a Routine of Facial Products in Subjects With Melasma · NA · not yet recruiting
NCT07537595 — Efficacy of Cosmetic Products in Preventing Pigmentation Induced by High Energy Visible Light (HEVL) [400-450nm] · completed
NCT06320314 — Efficacy and Tolerability of Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05989633 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cosmetique Active International
Last refreshed: 14 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05989633.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing